Clinical trial
Clinical Study of 68Ga-labeled Novel Nectin-4 Bicyclic Peptide PET/CT for Imaging of Solid Tumors With High Nectin-4 Expression
NCT07319130 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Soochow University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of 68Ga-labeled Novel Nectin-4 Bicyclic Peptide PET/CT for Imaging of Solid Tumors With High Nectin-4 Expression
- Lead sponsor
- The First Affiliated Hospital of Soochow University
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- July 3, 2025
- Completion date
- December 31, 2026
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumors with high expression of nectin4